Lynch & Associates’s Compugen CGEN Stock Holding History

Lynch & Associates’s Portfolio CGEN Stock Details CGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-10,000	Closed	-$39K	–	93
2018 Q3	$39K	Hold	10,000	–	–	0.01%	96
2018 Q2	$33K	Hold	10,000	–	–	0.01%	94
2018 Q1	$45K	Hold	10,000	–	–	0.02%	96
2017 Q4	$25K	Hold	10,000	–	–	0.01%	94
2017 Q3	$38K	Hold	10,000	–	–	0.02%	93
2017 Q2	$38K	Hold	10,000	–	–	0.02%	99
2017 Q1	$43K	Hold	10,000	–	–	0.02%	98
2016 Q4	$51K	Hold	10,000	–	–	0.02%	100
2016 Q3	$63K	Hold	10,000	–	–	0.03%	105
2016 Q2	$65K	Hold	10,000	–	–	0.03%	107
2016 Q1	$56K	Hold	10,000	–	–	0.03%	107
2015 Q4	$64K	Hold	10,000	–	–	0.03%	105
2015 Q3	$52K	Hold	10,000	–	–	0.03%	102
2015 Q2	$69K	Hold	10,000	–	–	0.04%	104
2015 Q1	$71K	Hold	10,000	–	–	0.04%	102
2014 Q4	$83K	Hold	10,000	–	–	0.04%	93
2014 Q3	$86K	Hold	10,000	–	–	0.05%	93
2014 Q2	$90K	Hold	10,000	–	–	0.05%	88
2014 Q1	$105K	Hold	10,000	–	–	0.06%	93
2013 Q4	$90K	Hold	10,000	–	–	0.05%	92
2013 Q3	$103K	Hold	10,000	–	–	0.07%	93
2013 Q2	$54K	Buy	+10,000	New	+$56.4K	0.04%	94

Other funds holding CGEN

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

TFCM

Taylor Frigon Capital Management Scottsdale, Arizona $176M AUM 24.25% 1-Year Est. Return

RIL

Rothschild Investment LLC Chicago, Illinois $1.91B AUM 24.37% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Defender Capital Charlotte, North Carolina $308M AUM 4.52% 1-Year Est. Return

BFEC

Benjamin F. Edwards & Company St. Louis, Missouri $5.69B AUM 15.37% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

MAA

Matrix Asset Advisors White Plains, New York $1.23B AUM 26.4% 1-Year Est. Return

Lynch & Associates's CGEN Position: Q4 2018 in Review

Lynch & Associates sold out of Compugen (CGEN) in Q4 2018, closing a stake of 10,000 shares — an estimated $39K sold.

Lynch & Associates first reported a position in CGEN in Q2 2013 and held it in 22 quarters. The position peaked at $105K in Q1 2014. 39 funds tracked by Wall St. Rank hold CGEN as of Q4 2018.

Lynch & Associates reported no remaining Compugen position as of Q4 2018 after selling out during the quarter.
Lynch & Associates sold 10,000 Compugen shares in Q4 2018, an estimated $39K.
Lynch & Associates first reported a position in Compugen in Q2 2013 and held it in 22 quarters.
Lynch & Associates's Compugen position peaked at $105K in Q1 2014.
39 funds tracked by Wall St. Rank held Compugen as of Q4 2018.

Based on Lynch & Associates's 13F filing for Q4 2018, filed 10 Jan 2019.